Form 8-K - Current report:
SEC Accession No. 0001641172-25-012181
Filing Date
2025-05-23
Accepted
2025-05-23 08:00:22
Documents
14
Period of Report
2025-05-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 46807
2 EX-4.1 ex4-1.htm EX-4.1 37268
3 EX-10.1 ex10-1.htm EX-10.1 104797
  Complete submission text file 0001641172-25-012181.txt   383893

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE vvos-20250523.xsd EX-101.SCH 3006
5 XBRL LABEL FILE vvos-20250523_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE vvos-20250523_pre.xml EX-101.PRE 24159
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3808
Mailing Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120
Business Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120 (866)908-4867
Vivos Therapeutics, Inc. (Filer) CIK: 0001716166 (see all company filings)

EIN.: 813224056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39796 | Film No.: 25979316
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)